Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: Analysis of factors associated with infection

Oral Surgery, Oral Medicine, Oral Pathology

Volumn 70, Issue 3, 1990, Pages 286-293

  Schubert, Mark M ^a   Peterson, Douglas E ^a   Flournoy, Nancy ^a   Meyers, Joel D ^a   Truelove, Edmond L ^a  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MOUTH INFECTION; PHARYNX DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, VIRAL; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HERPES LABIALIS; HUMAN; IMMUNOSUPPRESSION; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SIMPLEXVIRUS; STOMATITIS, HERPETIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025076681     PISSN: 00304220     EISSN: None     Source Type: Journal    
DOI: 10.1016/0030-4220(90)90142-F     Document Type: Article

References (42)

1. Herpes simplex infections in hematologic malignancies
2. Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: a prospective study
3. Cancer chemotherapy associated symptomatic stomatitis: role of herpes simplex virus (HSV)
4. Prospective study of prevalence, incidence, and source of herpes virus infections in patients with renal allografts
5. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation
6. Cellular immunity and herpes virus infections in cardiac transplant patients
7. Infectious complications of marrow transplantation
8. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant
9. Infectious disease during immune recovery after bone marrow transplantation
10. Herpes simplex virus pneumonia
11. Bone marrow transplantation
12. Bone marrow transplantation
13. Data management in medical research
14. Proportional hazards regression analysis
15. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients
16. Treatment of mucocutaneous herpes simplex virus infection after marrow transplantation with intravenous acyclovir
17. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
18. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients
19. Acyclovir prophylaxis of herpes-simplex-virus infections
20. Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients
21. Prevention of herpes simplex virus infections in renal allograft recipients by low-dose oral acyclovir
22. Infectious complications in heart-lung transplant recipients
23. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplant
24. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir
25. Isolation and characterization of resistant herpes simplex virus after acyclovir therapy
26. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir
27. Prophylaxis: a strategy to minimize antiviral resistance
28. The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy
29. A long-term prospective clinical study of orofacial herpes simplex virus infection in acute leukemia
30. Oral mucositis in patients undergoing bone marrow transplantation
31. Seroepidemiology of infections due to members of the herpes virus group
32. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia
33. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients
34. Acyclovir prophylaxis of herpes virus infections in severely immunocompromised patients: a randomized double-blind trial
35. Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy
36. Chronic oral herpes simplex virus infection in immunocompromised patients
37. Head and neck complications of bone marrow transplantation
38. Undiagnosed oral herpes in immunosuppressed patients
39. Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation
40. T cells and viral infections
41. Immunologic reconstitution after human marrow grafting
42. Oral herpes simplex infections in patients with leukemia